bearish

HLB Life Science: Impact of Rights Offering Capital Raise of 150 Billion Won

481 Views22 Mar 2024 18:19
On 21 March, HLB Life Science announced a rights offering capital raise worth 150 billion won. The expected rights offering price is 13,630 won (32% lower than current price of 19,930 won).
SUMMARY
(Sign Up to Access)
Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:
  • Unlock research summaries
  • Follow top, independent analysts
  • Receive personalised alerts
  • Access Analytics, Events and more

Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.

Upgrade later to our paid plans for full-access.

or
Already have an account? Sign In Now
Full Insight
(Paid Plans Only, 5-minute read)
Discussions
(Paid Plans Only)
chart-bar
Logo
Top 5%
Douglas Kim
Korea/Asia, Events, IPOs
Douglas Research Advisory
South KoreaEquity Bottom-UpEquity Capital Markets
Price Chart(Sign Up to Access)
analytics-chart
x